SARAH AMES: Open Payments
NPI 1194445452 · FREMONT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 17 payments from 13 companies in 2025. Trend: 2023 $75 · 2024 $695 · 2025 $298
Food & beverage: $271Education: $28
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $51 |
| PFIZER INC. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Madrigal Pharmaceuticals | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Antares Pharma, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: ELIQUIS, EOHILIA, REXULTI, UBRELVY, Dexcom G6 Transmitter, REZDIFFRA, NURTEC ODT, FARXIGA.
Industry payments across MI — which companies pay providers there.
